Ashifa Trivedi joins NHS LPP as the Chief Pharmaceutical Officer’s Clinical Fellow

Ashifa recently joined NHS LPP as a clinical fellow with the Medicines Optimisation and Pharmacy Procurement (MOPP) team as part of the Chief Pharmaceutical Officer’s Clinical Fellow Scheme.

How the Chief Pharmaceutical Officer’s Clinical Fellow Scheme works 

Sponsored by the Chief Pharmaceutical Officer of NHS England and managed by the Faculty of Medical Leadership and Management (FMLM), the scheme is designed to support and develop pharmacists who present with the clearest potential to develop as clinical leaders of the future. Clinical fellows work in an apprenticeship model to the most senior leaders in national NHS and healthcare-related organisations. This offers an unparalleled experience and the opportunity to develop a range of skills including leadership, management, strategy, project management and health policy. Within their host organisations, fellows lead on key projects which contribute to national healthcare priorities around patient safety, medicines optimisation, transfer of care, digitalisation and pharmacy workforce training.

About this appointment 

Ashifa worked at the Hillingdon Hospitals NHS Foundation Trust as lead pharmacist for Women and Children for the past six years. Her key responsibilities as a clinical fellow will include the delivery of the communication and engagement strategy for NHS LPP's MOPP team to support on the build and delivery of NHS LPP dashboards and working collaboratively in procurement projects on behalf of our members and other stakeholders in London's health economy.

 Ashifa 2

Ashifa has extensive experience working in secondary care, working both regionally and nationally on shared guidelines and best practice. She has led various quality improvement projects, including reducing paediatric prescribing errors, improving the rate of medicines reconciliation for paediatric patients and the implementation of the Discharge Medicines Service for paediatric patients. Ashifa’s commitment to advancing the field of pharmacy is evident through her extensive involvement in NICE guidelines as a committee member. She holds the role of DGH pharmacist representative on the Royal College of Paediatrics and Child Health (RCPCH) and Neonatal and Paediatric Pharmacy Group (NPPG) Medicines Committee and is also the EDI and diversity lead for the NPPG committee.

Ashifa said: "The fellowship serves as an enticing gateway to broaden my knowledge and gain invaluable experience across diverse sectors of the pharmacy field. In particular, the opportunity to be hosted by NHS London Procurement Partnership promises to bring a unique perspective to my professional development. I am looking forward to working with the MOPP team on behalf members to achieve the vision of supporting medicines optimisation through a pan-London approach aligned with the national priorities of quality, safety and value".

Jas Khambh, Chief Pharmacist & Clinical Director said: "We are very excited about Ashifa joining the team. We will be working on some interesting projects over the next few years and I have no doubt that Ashifa's insights and experience will contribute significantly to their advancement and success".